A moisture-resistant citric acid composite for effervescent tablet formulations that prevents premature CO2 release during storage. By loading citric acid into a mesoporous carrier, the formulation remains physically stable at high humidity (>70% RH), extending shelf life and product reliability for pharmaceutical, nutraceutical, and consumer effervescent products.
This technology addresses a long-standing stability challenge in effervescent tablet formulations. Citric acid, a key acid component that reacts with sodium hydrogen carbonate to release CO2, is prone to deliquescence under humid conditions. When citric acid absorbs moisture, it can prematurely react with hydrogen carbonate, causing product failure before use.
The solution involves loading citric acid into a mesoporous carrier to create a composite that remains physically stable even at relative humidity above 70%. The porous carrier physically separates citric acid from other tablet components during storage, preventing premature CO2 release. Upon contact with water, both components dissolve and react normally, delivering the intended effervescent function.
This technology is at an early-to-mid stage of development. Planned validation activities include preparing citric acid-carrier composites across a range of loading levels, evaluating physical stability of composites at elevated humidities to identify the optimal carrier type and loading, and formulating complete effervescent tablets to test physical stability under stressed conditions such as 40°C and 75% relative humidity. These studies will establish the formulation parameters and performance benchmarks needed for commercial development and scale-up.
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.